MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/jch.70350

Медицинская библиотека · Journal of clinical hypertension (Greenwich, Conn.) · 2026

Renin-Angiotensin System Inhibitor Use and Mortality in Older Hypertensive Patients With and Without Dementia: A Nationwide Registry-Based Cohort Study.

Villa Lopez Marta, Hoang Minh Tuan, Xu Hong, Norgren Jakob, Petek Bojana, Secnik Juraj, Kalar Irena, Religa Dorota, Maioli Silvia, Mo Minjia, Kåreholt Ingemar, Johnell Kristina, Cuadrado Maria-Luz, Eriksdotter Maria, Garcia-Ptacek Sara

СтатьяПеревод в очереди

Аннотация

Cardiovascular risk factors are often undertreated in patients with dementia. Renin-angiotensin system inhibitors (RASI) are first-line treatments for hypertension. We examined the association between RASI and all-cause mortality in hypertensive patients with and without dementia, comparing angiotensin-converting enzyme inhibitors (ACEI) to angiotensin receptor blockers (ARB); and selected individual agents. This nationwide register-based cohort study included data from Swedish national registries 2007-2018. The study included 158 176 hypertensive patients with exposure to RASI medications (21 152 RASI users and 137,024 non-users), after excluding prevalent users. Propensity score matching was used to balance measured confounders. Cox regressions compared mortality risk among RASI users versus non-users, ACEI users versus ARB users, and users of enalapril, ramipril, losartan, and candesartan versus other RASI users. RASI use was associated with lower all-cause mortality (hazard ratio[HR] 0.93, 95% confidence interval[CI] 0.91-0.95, p< 0.001) in the full cohort, and among patients with dementia (HR 0.88, 95% CI 0.85-0.92). Compared to ACEI, ARB were associated with lower mortality in the full cohort (HR 0.90, 95% CI 0.85-0.96), but results were not significant in patients with dementia. The comparison of the individual drugs were consistent with class-level findings. RASI use was associated with lower all-cause mortality among older hypertensive patients, including those with dementia. These observational findings support continued attention to evidence-based hypertension treatment in patients with dementia.

Для цитирования: Villa Lopez Marta, Hoang Minh Tuan, Xu Hong, Norgren Jakob, Petek Bojana, Secnik Juraj, Kalar Irena, Religa Dorota, Maioli Silvia, Mo Minjia, Kåreholt Ingemar, Johnell Kristina, Cuadrado Maria-Luz, Eriksdotter Maria, Garcia-Ptacek Sara. Renin-Angiotensin System Inhibitor Use and Mortality in Older Hypertensive Patients With and Without Dementia: A Nationwide Registry-Based Cohort Study.. Journal of clinical hypertension (Greenwich, Conn.). 2026. DOI: 10.1111/jch.70350.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.